A study of 30 years of anti-depressant drug treatment data was recently published in the Journal of the American Medical Association. The research team, led by psychologists at the University of Pennsylvania, concluded that the ability of antidepressant medications to reduce depressive symptoms varied considerably. They found that antidepressants were virtually no better than a placebo for people with mild or moderate depression. The benefit of antidepressant medications was shown to be substantial for patients with very severe depression.
Researchers looked at data from six studies that examined the effectiveness of two commonly prescribed anti-depressants, paroxetine and imipramine. Paroxetine is sold under the brand name Paxil and is one of a popular class of drugs known as selective serotonin reuptake inhibitors. Imipramine is an older tricyclic antidepressant drug.
The exact number of patients with milder cases of depression who take antidepressants is unknown. However, one survey cited by the researchers found that 71% of all patients seeking treatment for depression fall in the milder category. At least 27 million Americans take antidepressants and, according to IMS Health, more than 164 million prescriptions for antidepressants were written in 2008. Billions of dollars have been spent over the past few decades by people who might have done just as well by taking a placebo.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.